Healthcare

Veterinary Oncology Market Share By Cancer Type, Manufacturer, Industry Trend And Forecast 2023-2032|PetCure Oncology, Zoetis Inc, Karyopharm Therapeutics Inc, Varian Medical Systems Inc., Accuray Incorporated

Spread the love

The Veterinary Oncology Global Market Report 2023 by The Business Research Company, provides veterinary oncology market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Veterinary Oncology Market:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

According to The Business Research Company’s Veterinary Oncology Global Market Report 2023, the market size is expected to grow from $0.32 billion in 2022 to $0.36 billion in 2023 at a compound annual growth rate (CAGR) of 12.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global veterinary oncology market size is expected to reach $0.55 billion in 2027 at a CAGR of 11.5%.

The growing prevalence of cancer in pets is expected to propel the veterinary oncology market going forward. Cancer is a disorder in which a few of the body’s cells grow out of control and spread to other body sections. Cancer in pets refers to the physical manifestations of a tumor, such as swelling. Veterinary oncology is focused for cancer diagnosis and therapy in animals by reducing metastasis and disease spread. As a result, an increase in pet cancer will boost the need for veterinary oncology.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=9533&type=smp

The veterinary oncology market is segmented:

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Type

Product innovations are a key trend gaining popularity in the veterinary oncology market. Major companies operating in the veterinary oncology market are focused on developing new solutions to strengthen their position. For instance, in June 2021, PetDx, a US-based molecular diagnostics company dedicated to unleashing the power of genomics, launched “OncoK9,” a novel multi-cancer early detection test. It is uniquely designed with the power of genomics to help veterinarians detect cancer in dogs earlier by using routine blood drawing without the need for prior fasting or sample processing. It processes the sample using proprietary methods optimized for canine cell-free DNA analysis and issues a digital report indicating if there is a cancer signal. It has strong clinical performance with minimal false-positive rates and high cancer diagnosis rates.

The veterinary oncology market report table of contents includes:

  1. Executive Summary
  2. Veterinary Oncology Market Characteristics
  3. Veterinary Oncology Market Trends And Strategies
  4. Veterinary Oncology Market – Macro Economic Scenario
  5. Veterinary Oncology Market Size And Growth

 

.

.

.

  1. Middle East Veterinary Oncology Market
  2. Africa Veterinary Oncology Market
  3. Veterinary Oncology Market Competitive Landscape And Company Profiles
  4. Key Mergers And Acquisitions In The Veterinary Oncology Market
  5. Veterinary Oncology Market Future Outlook and Potential Analysis

Top Major Players

  • PetCure Oncology
  • Zoetis Inc
  • Karyopharm Therapeutics Inc
  • Varian Medical Systems Inc.
  • Accuray Incorporated

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Spread the love
Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [kalyani@topprnews.com}

Recent Posts

Plasma Powder Market Growth Outlook Through 2024-2033

Overview and Scope Plasma powder is a protein-rich ingredient derived from the spray-drying of plasma,…

5 hours ago

Pedestrian Bridge Market Report 2024: Size, Share, Trends, Growth Drivers, Forecast to 2033

Overview and Scope A pedestrian bridge is a constructed framework spanning a railway, river, or…

6 hours ago

Next-Generation Antibody Therapeutics Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope Next-generation antibody therapeutics are advanced antibody-based drugs in structure, functionality, and therapeutic…

6 hours ago

Neurological Biomarkers Market Opportunities 2024-2033: Size, Growth Analysis, Outlook, and Overview

Overview and Scope A neurological biomarker is a substance that provides objective and quantifiable information…

6 hours ago

Home Insurance Market Opportunities 2024-2033: Size, Growth Analysis, Outlook, and Overview

Overview and Scope Home insurance is a policy that pays for expenses and damage to…

7 hours ago

Extended-Release Drugs Market Size, Insights Forecast, Growth, Trends 2024-2033

Overview and Scope Extended-release drugs are a dosage form made to release the medication over…

7 hours ago